Certolizumab Subcutaneous and Lorcaserin Extended-Release Tablets
Determining the interaction of Certolizumab Subcutaneous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Certolizumab Subcutaneous-Lorcaserin Hydrochloride
- Certolizumab Subcutaneous-Lorcaserin Tablets
- Certolizumab Subcutaneous-Lorcet
- Certolizumab Subcutaneous-Lorcet Plus
- Certolizumab Subcutaneous-Lorcet Tablets
- Certolizumab Subcutaneous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Certolizumab Vials
- Lorcaserin Extended-Release Tablets-Cerubidine
- Lorcaserin Extended-Release Tablets-Cervarix
- Lorcaserin Extended-Release Tablets-Cervarix Intramuscular
- Lorcaserin Extended-Release Tablets-Cervidil
- Lorcaserin Extended-Release Tablets-Cesamet